尿微量白蛋白

同时能降低尿微量白蛋白、β2&微球蛋白排泄，改善肾脏血流动力学，保护肾脏。

It can also reduce ALB and P2-MG in urine and improve blood dynamics parameters , so as to protect kidney .

方法将59例过敏性紫癜患儿随机分成肝素钙治疗组和对照治疗组，另设非HSP对照组20例，追踪监测尿β2微球蛋白（β2M）、尿微量白蛋白（Alb）。

Methods The 59 HSP patients were divided into the heparin calcium treated group and the control group at random . β 2 M and Alb of urine were monitored constantly .

原发性高血压肾病患者血清胱抑素C和尿微量白蛋白检测的临床意义

Clinical Significance of Serum Cystatin C and Urine Microalbumin Levels in Patients with Primary Hypertension Nephropathy

2型糖尿病肾病患者尿微量白蛋白和血清高敏C反应蛋白检测的临床意义

Clinical significance of type 2 diabetes nephropathy patients with urinary albumin and serum high-sensitivity C-reactive protein testing

尿微量白蛋白ELISA测定法及其临床应用

Enzyme-linked immunosorbent assay ( elisa ) for microalbuminuria and its clinical use

尿微量白蛋白在评价直接PCI后心肌灌注的意义

Role of microalbuminuria in evaluation of myocardial reperfusion in primary percutaneous coronary intervention

结果治疗后患者的动脉血压明显降低（P＜0.001），尿微量白蛋白减低，肾素活性增高（P＜0.001），其他肾功能指标无变化。

Results The blood pressure and urinary albumin were decreased significantly after treatment ( P < 0.001 ) . No significant changes were observed on kidney function .

入选患者均留取标本检测24h尿微量白蛋白。

All patients were picked up urine in 24 hours to detect tiny urine albumin level .

结果：治疗组尿微量白蛋白下降比对照组明显（P0.01）。

RESULTS : The treatment group urine micro albumin drops is more obvious than the control group ( p0.01 ) .

2型糖尿病血浆PAI-1与尿微量白蛋白的相关性研究

Relations of the Level of Plasma PAI-1 with Urine Micro-albumin in Type 2 Diabetes Mellitus

HRV下降与年龄、性别、空腹血糖、24小时尿微量白蛋白及周围神经病变有关。

Reduced HRV was correlated with age , sex , FBG , 24 hours microalbuminuria and peripheral neuropathy .

分析高血压肾损害患者尿微量白蛋白、RI与中医证型及PWV、ABI关系。

Analyze the relationship between microalbuminuria , RI and TCM syndrome and PWV , ABI .

目的探讨血清胱抑素C在2型糖尿病不同肾损害期的变化及其临床意义，比较血清胱抑素C与肾小球滤过率、尿微量白蛋白排泄率间的相关性。

Objective To investigate the difference of serum cystatin C ( CysC ) in different stage of renal impairment in type 2 diabetic patients and compare the relationship of cystatin C with glomerular filtration rate and UAER .

结论：α1-微球蛋白、尿微量白蛋白和转铁蛋白、尿IgG可作为发现系统性红斑狼疮早期肾损害敏感的常规指标。

Conclusion : α 1-microglobulin and urine trace albumin and transferring and urine IgG may to become earlier period kidney lesion marker in systemic lupus erythematosus .

对41例Ⅱ、Ⅲ期原发性高血压患者尿微量白蛋白（ALb），球蛋白（IgG）及其清除率进行观察。

Trace proteinuria and clearance of albumin and IgG were determined in 41 patients with essential hypertension in stages ⅱ and ⅲ .

目的研究贝那普利对老年糖尿病肾病（DN）早期尿微量白蛋白排泄率（UAE）及肾功能的影响。

Objective To study the effect of benazepril on urine minim albumin in patients with senile diabetic nephropathy ( DN ) .

尿微量白蛋白、β2-微球蛋白、NAG对肝硬化早期肾损害诊断意义

Study on the significance of measurement UM-Alb , U β _2-MG , NAG-U for diagnosis of cirrhosis with early renal lesion

治疗前后各查一次24h尿微量白蛋白（UAER）、肾功能BUN、Cr、UA及血压等。

Urinary albumin of 24 hours ( UAER ), renal function , Cr , UA and blood pressure were detected before and after the treatment .

方法：采用前后对照方法，分别检测治疗前后尿微量白蛋白（Alb）、空腹血糖（FBG）及血压进行比较分析。

Methods : To compare and analyze microdosis urinary albumin ( Alb ), fasting blood glucose ( FBG ) and blood pressure before and after treatment .

目的探讨2型糖尿病（T2DM）患者超敏C-反应蛋白（hs-CRP）水平与尿微量白蛋白相互关系。

Objective To explore the relationship between high sensitivity C-reactive protein ( hs-CRP ) level and microalbuminuria in patients with type 2 diabetes .

结果糖肾汤能降低早期糖尿病肾病模型大鼠血糖、尿微量白蛋白、尿蛋白，提高肾组织SOD水平，减少肾组织MDA含量。

Results : Tangshen decoction could reduce the level of blood sugar and urine albumen , improve the level of SOD and reduce the content of MDA in kidney tissue of early diabetic nephropathy rats .

观察治疗前后症状积分变化，测定空腹血糖（FPS）、尿微量白蛋白排泄率（UAER）、血清NO水平及SOD活性。

Changes of symptoms , fasting plasma sugar ( FPS ), urine albumin excretion ratio ( UAER ), NO level and SOD activity in serum were observed .

在临床上DN早期出现尿微量白蛋白，继之出现临床蛋白尿，最终发展成为慢性肾功能不全。

In the clinic , the early change of DN is appearing urine microalbumin , and then , it appears the clinical albuminuria , ultimately , it get into chronic renal insufficiency .

目的了解α1-微球蛋白（α1-mG）与尿微量白蛋白（u-Alb）对系统性红斑狼疮（SLE）患者早期肾损害的诊断价值。

Objective To discover the diagnose value of the urinary α 1 - microglobulin (α 1 - mG )、 albumin to the early lupus nephritis .

观察治疗前后两组临床症状积分、肾功能、尿微量白蛋白排泄率或24h尿蛋白定量、血C反应蛋白和尿转化生长因子β1的变化。

After two months course of treatment , the changes of clinical symptomatic score , renal function , excretory rate of trace urinary albumin , urinary protein quantity in 24 hours , CRP and urine TGF - β 1 were observed .

结果：小剂量肝素与前列腺素E1皆可降低早期糖尿病肾病者尿微量白蛋白（均P<0.05），治疗后两组间尿微量白蛋白无显著性差异（P>0.05）；

Results : Both groups showed that urine micro albumin decreased ( P < 0.05 ) . There was no significant difference between the two groups ( P > 0.05 ) .

目的探讨尿微量白蛋白（Alb）、转铁蛋白（TRF）、α1-微球蛋白（α1-MG）、免疫球蛋白IgG含量测定对慢性阻塞性肺病（ChronicObstructivepulmonaryDisease，COPD）早期肾功能损害的临床意义。

Objective To investigate the clinical significance of microalbunminuria ( mAlb ), transferrin ( TRF ), alpha-1-microglobulin (α 1-MG ), immunity globulin IgG content determination for the kidney function harm of chronic obstructive pulmonary disease ( COPD ) .

目的：探讨β受体阻断剂卡维地洛对2型糖尿病合并高血压患者尿微量白蛋白（UA）的治疗作用。

Objective : study the therapeutic efficacy of carvedilol , a b receptor blocker , on the microalbuminuria ( U MA ) in patients of type II diabetes mellitus complicated with hypertension .

血浆PAI-1与尿微量白蛋白成正相关，表明PAI-1可能是糖尿病血管并发症发生的一个危险因素。

Plasma PAI-1 and urine microalbumin in patients with type 2 diabetes mellitus hade a positive correlation . It showed that PAI-1 may be one of the factors that occurred the vascular complications .

结果体外循环冠脉搭桥组尿微量白蛋白与尿肌酐比值（m-Alb/Cr）、尿N-乙酸-β-D氨基葡萄糖苷酶（NAG）浓度组内各点相比，T1与T0比较差异有统计学意义（P<0.05）。

Results The ratio of urinary microalbumin to creatinine and NAG levels increased significantly at T_1 as compared with that at T_0 in on-pump coronary revascularization ( P < 0.05 ) .